Pivotal bioVenture Partners Fund I, L.P.'s Net Worth
-$12.5 Million
Who is Pivotal bioVenture Partners Fund I, L.P.?
Pivotal bioVenture Partners Fund I, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Inozyme Pharma, Inc., Entasis Therapeutics Holdings Inc., and Akouos, Inc..
SEC CIK
Pivotal bioVenture Partners Fund I, L.P.'s CIK is 0001695076
Past Insider Trading and Trends
2020 was Pivotal bioVenture Partners Fund I, L.P.'s most active year for acquiring shares with 4 total transactions. Pivotal bioVenture Partners Fund I, L.P.'s most active month to acquire stocks was the month of August. 2018 was Pivotal bioVenture Partners Fund I, L.P.'s most active year for disposing of shares, totalling 2 transactions. Pivotal bioVenture Partners Fund I, L.P.'s most active month to dispose stocks was the month of August. 2018 saw Pivotal bioVenture Partners Fund I, L.P. paying a total of $5,065,860.00 for 1,155,416 shares, this is the most they've acquired in one year. In 2020 Pivotal bioVenture Partners Fund I, L.P. cashed out on 11,989,481 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inozyme Pharma, Inc. (INZY) Snapshot price: $5.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.76% | 833.33K |
$4.80 | $3,999,998.40 | 4.49M |
Aug 1
| |||
Form 4
| +67.25% | 1.07M |
$3.69 | $3,948,300.00 | 2.66M |
Apr 19
| |||
Form 4
|
∞
| 1.59M |
$16.00 |
—
| 1.59M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +300.87% | 1.16M |
$15.00 |
—
| 1.54M |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akouos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.79M |
$17.00 |
—
| 1.79M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||